SCHEMBL21775697

SCHEMBL21775697

Cc1cc(OC(C)OC(=O)C2CC2)n(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.42
TSHR P16473 2/20 0.41
ALDH1A1 P00352 5/20 0.41
GAA P10253 3/20 0.40
SMYD3 Q9H7B4 1/20 0.40
P2RY1 P47900 1/20 0.40
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
KCNJ6 P48051 1/20 0.39
KCNJ5 P48544 1/20 0.39
KCNJ3 P48549 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATM Q13315 1/20 0.38
KMT2A Q03164 1/20 0.38
RIPK1 Q13546 1/20 0.38
FCGR1A P12314 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775698 0.95 ALDH1A1 (0.41) NTRK1TSHRALDH1A1GAASMYD3
SCHEMBL25763290 0.94 LMNA (0.41) NTRK1TSHRALDH1A1GAASMYD3
SCHEMBL21775684 0.84 NTRK1 (0.47) NTRK1TSHRALDH1A1GAAP2RY1
SCHEMBL21775689 0.83 GAA (0.45) NTRK1TSHRALDH1A1GAAP2RY1
SCHEMBL21774341 0.83 NTRK1 (0.46) NTRK1TSHRALDH1A1GAAP2RY1
SCHEMBL21775688 0.82 NTRK1 (0.45) NTRK1TSHRALDH1A1GAAP2RY1
SCHEMBL21775728 0.82 ALDH1A1 (0.53) NTRK1TSHRALDH1A1GAAP2RY1
SCHEMBL21775729 0.79 TSHR (0.48) NTRK1TSHRALDH1A1GAAP2RY1
SCHEMBL21774380 0.79 GAA (0.48) NTRK1TSHRALDH1A1GAAMAPT
SCHEMBL21774370 0.76 FAAH (0.43) NTRK1ALDH1A1GAAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
WO-2020038279-A1 SUBSTITUTED PYRAZOLE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF 天津谷堆生物医药科技有限公司 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof FARS2, GOT2, HADHB NTRK1 2744/4885TSHR 4169/4885ALDH1A1 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.